Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
MiMedx Group
MDXG
$624M
| $11M | 0.02% |
1,251,785
+168,700
| +16% | +$1.24M |
|
|
ITCI
902
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $10.9M | 0.02% |
152,400
-111,600
| -42% | -$6.42M |
|
903
Polaris
PII
$3.9B
| $10.9M | 0.02% |
+115,100
| New | +$10.5M |
|
|
CFLT
904
DELISTED
Confluent
CFLT
| $10.9M | 0.02% |
465,902
-214,498
| -32% | -$5.18M |
|
905
Banco Bradesco
BBD
$34.3B
| $10.9M | 0.02% |
3,107,595
-23,300
| -0.7% | -$73.1K |
|
906
Western New England Bancorp
WNEB
$282M
| $10.8M | 0.02% |
1,201,517
+6,169
| +0.5% | +$47.1K |
|
907
RE/MAX Holdings
RMAX
$263M
| $10.8M | 0.02% |
811,100
-138,700
| -15% | -$1.52M |
|
|
CMRC
908
Commerce.com Inc Series 1
CMRC
$179M
| $10.8M | 0.02% |
1,110,500
+260,700
| +31% | +$2.42M |
|
909
Braskem
BAK
$825M
| $10.8M | 0.02% |
1,223,801
+355,201
| +41% | +$2.71M |
|
910
iShares Convertible Bond ETF
ICVT
$7.64B
| $10.8M | 0.02% |
+137,100
| New | +$10.2M |
|
911
Strategic Education
STRA
$1.81B
| $10.8M | 0.02% |
116,381
-19,497
| -14% | -$1.69M |
|
912
BGC Group
BGC
$5.12B
| $10.7M | 0.02% |
1,487,648
-389,600
| -21% | -$2.41M |
|
913
Advanced Drainage Systems
WMS
$11.3B
| $10.7M | 0.02% |
+76,280
| New | +$9.2M |
|
|
LKFT
914
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
| $10.7M | 0.02% |
263,200
-18,600
| -7% | -$684K |
|
915
Reinsurance Group of America
RGA
$16.1B
| $10.6M | 0.02% |
65,800
+500
| +0.8% | +$77.8K |
|
916
ManpowerGroup
MAN
$2.61B
| $10.6M | 0.02% |
133,052
-38,600
| -22% | -$2.87M |
|
917
California Resources
CRC
$4.69B
| $10.5M | 0.02% |
192,836
-284,600
| -60% | -$15M |
|
918
UWM Holdings
UWMC
$2.42B
| $10.5M | 0.02% |
1,474,200
-3,900
| -0.3% | -$22K |
|
919
Invesco Variable Rate Preferred ETF
VRP
$3.01B
| $10.5M | 0.02% |
456,402
+279,043
| +157% | +$6.25M |
|
920
StepStone Group
STEP
$3.96B
| $10.5M | 0.02% |
330,700
-54,364
| -14% | -$1.54M |
|
921
Omega Healthcare
OHI
$13.9B
| $10.5M | 0.02% |
+343,278
| New | +$11M |
|
922
BioCryst Pharmaceuticals
BCRX
$2.71B
| $10.5M | 0.02% |
1,754,980
+1,553,135
| +769% | +$9M |
|
923
Future Fuel
FF
$249M
| $10.5M | 0.02% |
1,728,400
+280,800
| +19% | +$1.79M |
|
|
NOA
924
North American Construction
NOA
$414M
| $10.5M | 0.02% |
503,500
-53,000
| -10% | -$1.09M |
|
925
Chubb
CB
$132B
| $10.4M | 0.02% |
+46,199
| New | +$10.1M |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.